13:15 ET
Investment will create up to 2,170 jobs and promote innovation in Canada's life sciences industry VANCOUVER, April 25, 2018 /CNW/ - The Canadian...
10:19 ET
MONTREAL, April 25, 2018 /CNW Telbec/ - The IRIC is proud to announce the $12.8 million in funding awarded to the "Interrogating and implementing...
08:05 ET
TORONTO, April 25, 2018 /CNW/ - Beleave Inc. ("Beleave" or the "Company") (CSE: BE; OTCQX: BLEVF) in reference to its previously announced...
07:00 ET
HOUSTON, TX and VANCOUVER, April 25, 2018 /CNW/ - ESSA Pharma Inc. ("ESSA" or the "Company") (TSX-V: EPI, NASDAQ: EPIX), a pre-clinical stage...
Apr 24, 2018, 20:41 ET
TORONTO, April 24, 2018 /CNW/ - Beleave Inc. ("Beleave" or the "Company") (CSE: BE; OTCQX: BLEVF) is pleased to announce its intention to complete...
Apr 24, 2018, 07:30 ET
HOUSTON and VANCOUVER, April 24, 2018 /CNW/ - ESSA Pharma Inc. ("ESSA" or the "Company") (NASDAQ: EPIX, TSX-V: EPI), a pharmaceutical company...
Apr 24, 2018, 07:00 ET
TSXV: DVA TORONTO, April 24, 2018 /CNW/ - Delivra Corp. ("Delivra", or "the Company") today announced the ability to treat pain directly with a...
Apr 24, 2018, 01:37 ET
Connect Biopharmaceuticals, Ltd. today announced that it has submitted an application in Australia to begin a phase 1 clinical trial to evaluate...
Apr 23, 2018, 08:00 ET
OTTAWA, April 23, 2018 /CNW/ - The Cannabis Canada Association (CCA), Canadian Medical Cannabis Council (CMCC), as well as Canopy Growth...
Apr 20, 2018, 09:00 ET
Indivior PLC (LON: INDV) today announced that it has filed a New Drug Submission (NDS) with Health Canada's Therapeutic Drugs Directorate for...
Apr 19, 2018, 19:38 ET
HOUSTON and VANCOUVER, April 19, 2018 /CNW/ - ESSA Pharma Inc. ("ESSA" or the "Company") (TSX-V: EPI, NASDAQ: EPIX), a pre-clinical stage...
Apr 19, 2018, 09:43 ET
OTTAWA, April 19, 2018 /CNW/ - The following statement can be attributed to Pamela Fralick, President, Innovative Medicines Canada. "Innovative...
Apr 18, 2018, 09:05 ET
Swift Biosciences today announced the commercial release of its Accel-Amplicon Plus™ Cancer NGS Panels, a suite of nine tumor-specific and focused...
Apr 18, 2018, 07:00 ET
TSXV: DVA TORONTO, April 18, 2018 /CNW/ - Delivra Corp. ("Delivra", or "the Company") today announced the publication of positive data from a...
Apr 17, 2018, 19:49 ET
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN...
Apr 17, 2018, 07:00 ET
- Two posters reporting activity for SRA737 with PARPi (in CCNE1-driven cancers, HRR proficient cancers, and PARPi-resistant cancers) reinforce the...
Apr 17, 2018, 06:48 ET
Sotera Health LLC, the world's leading, fully integrated protector of global health, today announced that it has entered into a definitive asset...
Apr 17, 2018, 05:30 ET
GB Sciences, Inc. (OTCQB: GBLX), as previously reported, plans to file an Exploratory IND and perform a Phase 0 Clinical Trial to gather valuable...
Apr 16, 2018, 18:22 ET
JHL Biotech announced today that the China Food and Drug Administration (CFDA) has accepted for review JHL's Clinical Trial Application for a...
Apr 16, 2018, 09:22 ET
TORONTO, April 13, 2018 /CNW/ - Beleave Inc. ("Beleave" or the "Company") (CSE: BE; OTCQX: BLEVF) is pleased to announce that its wholly-owned...